2004 Dosage Process Improvement 
ISPE
SEPTEMBER 11, 2023
POD is suitable for a wide range of products, including oral solid dosage forms, mAbs, and cell therapy. September 2004. Distributed Manufacturing and Point-of-Care Manufacturing of Drugs.” “Developing the Biofacility of the Future Based on Continuous Processing and Single-Use Technology.” September 2004. 2 (1 May 2005).
ISPE
AUGUST 30, 2022
In the long term, a collaboration between regulators and industry stakeholders to develop and implement harmonized guidelines for raw materials would help address flexibility challenges, prevent delays in implementing process improvements, and ensure that both regulator and industry resources are devoted to the most critical issues.
Expert insights. Personalized for you.
52 
Let's personalize your content